Apexigen Stock Shares Outstanding
| APGNDelisted Stock | USD 0.43 0.01 2.27% |
Apexigen fundamentals help investors to digest information that contributes to Apexigen's financial success or failures. It also enables traders to predict the movement of Apexigen Stock. The fundamental analysis module provides a way to measure Apexigen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apexigen stock.
Apexigen |
Apexigen Company Shares Outstanding Analysis
Apexigen's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Apexigen Shares Outstanding | 24.86 M |
Most of Apexigen's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apexigen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Apexigen has 24.86 M of shares currently outstending. This is 86.23% lower than that of the Biotechnology sector and 76.73% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 95.65% higher than that of the company.
Apexigen Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apexigen's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apexigen could also be used in its relative valuation, which is a method of valuing Apexigen by comparing valuation metrics of similar companies.Apexigen is currently under evaluation in shares outstanding category among its peers.
Apexigen Fundamentals
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 | |||
| Current Valuation | 205.33 K | |||
| Shares Outstanding | 24.86 M | |||
| Shares Owned By Insiders | 8.81 % | |||
| Shares Owned By Institutions | 13.54 % | |||
| Number Of Shares Shorted | 64.45 K | |||
| Price To Book | 2.32 X | |||
| EBITDA | (32.58 M) | |||
| Net Income | (32.07 M) | |||
| Cash And Equivalents | 21.62 M | |||
| Cash Per Share | 1.01 X | |||
| Total Debt | 106 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 1.24 X | |||
| Book Value Per Share | (0.09) X | |||
| Cash Flow From Operations | (30.69 M) | |||
| Short Ratio | 1.72 X | |||
| Earnings Per Share | (1.71) X | |||
| Target Price | 0.64 | |||
| Number Of Employees | 11 | |||
| Beta | 3.62 | |||
| Market Capitalization | 9.57 M | |||
| Total Asset | 22.86 M | |||
| Retained Earnings | (176.79 M) | |||
| Working Capital | 4.73 M | |||
| Z Score | 38.91 | |||
| Net Asset | 22.86 M |
About Apexigen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apexigen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apexigen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apexigen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Apexigen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apexigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apexigen will appreciate offsetting losses from the drop in the long position's value.Moving against Apexigen Stock
| 0.46 | MSFT | Microsoft Aggressive Push | PairCorr |
The ability to find closely correlated positions to Apexigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apexigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apexigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apexigen to buy it.
The correlation of Apexigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apexigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apexigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Apexigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |